Cellular signaling by tyrosine phosphorylation in keloid and normal human dermal fibroblasts

被引:38
作者
Chin, GS [1 ]
Liu, W [1 ]
Steinbrech, D [1 ]
Hsu, M [1 ]
Levinson, H [1 ]
Longaker, MT [1 ]
机构
[1] NYU, Med Ctr, Dept Surg, Lab Dev Biol & Repair, New York, NY 10016 USA
关键词
D O I
10.1097/00006534-200012000-00014
中图分类号
R61 [外科手术学];
学科分类号
摘要
Keloids represent a dysregulated response to cutaneous wounding that results in disfiguring scars. Unique to humans, keloids are characterized by an accumulation of extracellular matrix components. The underlying molecular mechanisms of keloid pathogenesis, however, remain largely uncharacterized. Similarly, cellular signaling mechanisms, which may indicate inherent differences in the way keloid fibroblasts and normal human dermal fibroblasts interact with extracellular matrix or other cells, have not been investigated. As part of a fundamental assessment of cellular response to injury in keloid fibroblasts, phosphorylation studies were performed using three different keloid (n = 3) and normal human dermal (n = 3) fibroblast cell lines. These studies were undertaken to elucidate whether keloid and normal human dermal fibroblasts exhibit different tyrosine kinase activity. Initially, distinct tyrosine phosphorylation patterns of keloid and normal human dermal fibroblasts were demonstrated, Next, the phosphorylation patterns were correlated with known molecules that may be important to keloid pathogenesis. On the basis of molecular weight, it was hypothesized that the highly phosphorylated bands seen in keloid fibroblasts represented epidermal growth factor receptor (EGFR); discoidin domain receptor 1 (DDR1); and Shc, an adaptor protein known to bind many tyrosine kinases, including EGFR and DDR1. Individual immunoblotting using EGFR, DDR1, and Shc antibodies revealed greater expression in keloid fibroblasts compared with normal human dermal fibroblasts. These data substantiate for the first time the finding of greater phosphorylation by the above-mentioned molecules, which may be important in keloid pathogenesis.
引用
收藏
页码:1532 / 1540
页数:9
相关论文
共 70 条
  • [51] CONTROL OF SCARRING IN ADULT WOUNDS BY NEUTRALIZING ANTIBODY TO TRANSFORMING GROWTH-FACTOR-BETA
    SHAH, M
    FOREMAN, DM
    FERGUSON, MWJ
    [J]. LANCET, 1992, 339 (8787) : 213 - 214
  • [52] Smith K, 1998, PIANO KEYBOARD, V1, P49
  • [53] TGF-β2 activates proliferative scar fibroblasts
    Smith, P
    Mosiello, G
    Deluca, L
    Ko, F
    Maggi, S
    Robson, MC
    [J]. JOURNAL OF SURGICAL RESEARCH, 1999, 82 (02) : 319 - 323
  • [54] SMITH P, 1998, WOUND RESP REGEN, V6, P264
  • [55] Receptors: Structure and function
    Stone, DK
    [J]. AMERICAN JOURNAL OF MEDICINE, 1998, 105 (03) : 244 - 250
  • [56] A MODEL OF SCARLESS HUMAN FETAL WOUND REPAIR IS DEFICIENT IN TRANSFORMING GROWTH-FACTOR-BETA
    SULLIVAN, KM
    LORENZ, HP
    MEULI, M
    LIN, RY
    ADZICK, NS
    [J]. JOURNAL OF PEDIATRIC SURGERY, 1995, 30 (02) : 198 - 203
  • [57] INTERACTION OF EPIDERMAL GROWTH-FACTOR WITH SPECIFIC BINDING-SITES OF ENTEROCYTES ISOLATED FROM RAT SMALL-INTESTINE DURING DEVELOPMENT
    TOYODA, S
    LEE, PC
    LEBENTHAL, E
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 886 (02) : 295 - 301
  • [58] Transforming growth factor-β in thermally injured patients with hypertrophic scars:: Effects of interferonα-2b
    Tredget, EE
    Shankowsky, HA
    Pannu, R
    Nedelec, B
    Iwashina, T
    Ghahary, A
    Taerum, TV
    Scott, PG
    [J]. PLASTIC AND RECONSTRUCTIVE SURGERY, 1998, 102 (05) : 1317 - 1328
  • [59] TUAN T, 1991, KELOIDS HYPERTROPHIC, P125
  • [60] Elevated levels of plasminogen activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts
    Tuan, TL
    Zhu, JY
    Sun, B
    Nichter, LS
    Nimni, ME
    Laug, WE
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (05) : 1007 - 1011